But first the placebo must be tried, which solves the problem of the effect of belief, hope and expectation on symptoms. As a clinical trial participant, you are assigned to one of the arms of a study, and you do will not know whether you are taking the placebo pill or the real drug.
Double Blinded Studies
"Blinded" means that neither the participants nor the researchers directly involved with the patients know who is getting the placebo. A "placebo-controlled double-blind study with randomized assignment" is the study design of choice for clinical trials because it contains "controls" for all of the potential problems that can arise from expectancy and belief effects. In this sort of clinical trial, a placebo arm or group is used to handle expectations of improvement, persons are randomly assigned to either the placebo arm or the treatment arm so no bias can influence the composition of the two groups. Only at the end of the trial are the assignment codes broken so that investigators can tell who was on placebo and who was on the drug.
When you participate in a placebo-controlled, double-blind study with random assignment to groups, you will be randomly assigned to either the treatment arm (where you will receive the actual drug) or to the placebo arm of the study. You will not know what arm you ended up in. Nor will the investigators, that is until they break the assignment codes at the end of the study. After the end of the study the effects of the drug on people in the treatment arm will be compared to effects of the placebo on people in the placebo arm. Hopefully the symptoms will be better treated in people who received the real drug when compared to the symptoms of people who were assigned to the placebo arm. Now if it is found that the drug was more effective than the placebo then people who had originally been assigned to the placebo arm will be given a chance to receive the drug while under supervision of the study investigators.
Fabrizio Bendetti, Placebo Effects: Understanding the mechanisms in health and disease, Oxford University Press, 2008.
Allan Hackshaw, "A Concise Guide to Clinical Trials," BMJ Books 2009.